People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...
Seven-year follow-up data show that transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement have ...
People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial ...
People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...
Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomimetic valve designed for physioloGic flow compared to CoMmercial TAVR devices MINNEAPOLIS and ...
People who underwent a minimally invasive procedure to have their heart's aortic valve replaced had similar health outcomes ...
The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...
DurAVR ® THV delivered a favorable hemodynamic profile sustained to one-year, with an EOA of 2.1 + 0.2 cm 2 and a mean pressure gradient (MPG) of 8.6 + 2.6 mmHg. At one-year, clinical safety outcomes ...
A troubling rise in severe diverticulitis cases among Americans under 50 highlights a significant public health concern.